Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

Authors: Isabelle Ray‐Coquard, Jean‐Yves Blay, Antoîne Italiano, Axel Le Cesne, Nicolas Penel, Jianguo Zhi, Florian Heil, Ruediger Rueger, Bradford Graves, Meichun Ding, David Geho, Steven A. Middleton, Lyubomir T. Vassilev, Gwen Nichols, Binh Bui - The Lancet 2012 cited by 563